ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Allometric dosing of miltefosine for treatment of visceral leishmaniasis in children <12 years

Allometric dosing of miltefosine for treatment of visceral leishmaniasis in children <12 years
Total daily allometric miltefosine dose (mg) for patient of indicated height (cm)*
Weight (kg) 60 70 80 90 100 110 120 130 140 150 175 200
Males
9 30 40 40 40 40              
12 40 40 40 50 50 50            
15   40 50 50 60 60 60          
20     50 60 60 70 70 70        
25       60 70 70 80 80 80      
30         80 80 90 90 90 100    
35         80 90 90 100 100 100 110  
40         80 90 100 100 110 110 120 130
45         90 90 100 110 110 120 130 130
50         90 100 100 110 120 120 130 140
55         90 100 110 120 120 130 140 150
60         90 100 110 120 130 130 150 150
65         100 110 110 120 130 140 150 150
75         100 110 120 130 140 140 150 150
85         100 110 120 130 140 150 150 150
Females
9 30 30 30 30 30              
12 30 30 40 40 40 40            
15   40 40 40 50 50 50          
20     50 50 50 60 60 60        
25       60 60 60 70 70 70      
30       60 60 70 70 80 80 80    
35       60 70 70 80 80 80 90 90  
40       70 70 80 80 90 90 90 100 110
45       70 80 80 90 90 100 100 110 110
50       70 80 80 90 100 100 100 110 120
55       70 80 90 90 100 100 110 120 130
60       70 80 90 100 100 110 110 120 130
65       80 80 90 100 110 110 120 130 140
75       80 90 100 100 110 120 120 140 150
85       80 90 100 110 120 120 130 150 150

* The total daily dose was calculated with equation 6 and rounded to the nearest 10 mg (smallest available capsule). To reduce the risk of gastrointestinal side effects upon intake, daily doses are best divided into 3 and given with 8 hour intervals between doses.

¶ A dose of 150 mg is considered to be the maximal tolerable dose that can be administered on a daily basis to a patient.
From: Dorlo TPC, Huitema ADL, Beijnen JH, de Vries PJ. Optimal dosing of miltefosine in children and adults with visceral leishmaniasis. Antimicrobial Agents and Chemotherapy 2012; 56:3864. DOI: 10.1128/AAC.00292-12. Copyright © 2012 American Society for Microbiology. Reproduced with permission from American Society for Microbiology.
Graphic 121724 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟